# The cardiac phospho-proteome during pressure overload in mice

**Authors:** Rhys Wardman, Steve Grein, Jennifer Schwartz, Frank Stein, Joerg Heineke

PMC · DOI: 10.1038/s41597-025-05506-7 · Scientific Data · 2025-08-02

## TL;DR

This study maps changes in heart proteins and phosphorylation events in mice under pressure overload, offering insights into heart failure mechanisms.

## Contribution

The study provides a detailed phospho-proteomic database of cardiac responses to pressure overload in mice.

## Key findings

- Thousands of proteins and phosphorylation sites were quantified, revealing hundreds of differential phosphorylation events.
- Significant changes were observed in hypertrophic signaling, metabolic remodelling, contractile function, and stress response pathways.
- Cellular localization of phospho-proteins in endothelial cells, fibroblasts, and cardiomyocytes was identified.

## Abstract

Transaortic constriction (TAC) is a murine model of pressure overload-induced cardiac hypertrophy and heart failure. Despite its high prevalence during aortic stenosis or chronic arterial hypertension, the global alterations in cardiac phospho-proteome dynamics following TAC remain incompletely characterised. We present a database of the phospho-proteomic signature one day and seven days after TAC. Utilising proteomic and phospho-proteomic analyses, we quantified thousands of proteins and phosphorylation sites, revealing hundreds of differential phosphorylation events significantly altered in the cardiac response to pressure overload. Our analysis highlights significant changes in hypertrophic signalling, metabolic remodelling, contractile function, and the stress response pathways. We present proteomic data from the main cardiac cell types (endothelial cells, fibroblasts and cardiomyocytes) to reveal the cellular localisation of the detected phospho-proteins, offering insights into temporal and site-specific phosphorylation events, facilitating the potential discovery of novel therapeutic targets and biomarkers. By making this resource publicly available (ProteomeXchange with identifier PXD061784) we aim to enable further exploration of the molecular basis of cardiac remodelling and advance translational research in heart failure.

## Linked entities

- **Diseases:** heart failure (MONDO:0005252), aortic stenosis (MONDO:0042981)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Copa (coatomer protein complex subunit alpha) [NCBI Gene 12847] {aka xenin}, Camk2d (calcium/calmodulin-dependent protein kinase II, delta) [NCBI Gene 108058] {aka 2810011D23Rik, 8030469K03Rik, CaMK II, [d]-CaMKII}, Dnase1 (deoxyribonuclease I) [NCBI Gene 13419] {aka DNaseI, Dnl1}, Ryr2 (ryanodine receptor 2, cardiac) [NCBI Gene 20191] {aka 9330127I20Rik, RYR-2}, Myl2 (myosin, light polypeptide 2, regulatory, cardiac, slow) [NCBI Gene 17906] {aka Gm32672, MLC-2, MLC-2s/v, MLC-2v, Mlc2v, Mylpc}, sty (small thymus) [NCBI Gene 20914], Lmod2 (leiomodin 2 (cardiac)) [NCBI Gene 93677] {aka C-Lmod}, Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, Mapk3 (mitogen-activated protein kinase 3) [NCBI Gene 26417] {aka Erk-1, Erk1, Ert2, Esrk1, Mnk1, Mtap2k}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Pdha1 (pyruvate dehydrogenase E1 alpha 1) [NCBI Gene 18597] {aka Pdha-1}, Ldb3 (LIM domain binding 3) [NCBI Gene 24131] {aka PDLIM6, ZASP}, Acan (aggrecan) [NCBI Gene 11595] {aka Agc, Agc1, CSPCP, Cspg1, b2b183Clo, cmd}, Mylpf (myosin light chain, phosphorylatable, fast skeletal muscle) [NCBI Gene 17907] {aka 2410014J02Rik, MLC-2, Mlc2, Myl11}, Mapk14 (mitogen-activated protein kinase 14) [NCBI Gene 26416] {aka CSBP2, Crk1, Csbp1, Mxi2, PRKM14, PRKM15}, Eno3 (enolase 3, beta muscle) [NCBI Gene 13808] {aka Eno-3, MSE}, Myh7 (myosin, heavy polypeptide 7, cardiac muscle, beta) [NCBI Gene 140781] {aka B-MHC, MYH-beta/slow, MyHC-I, Myhc-b, Myhcb, beta-MHC}, Ttn (titin) [NCBI Gene 22138] {aka 1100001C23Rik, 2310036G12Rik, 2310057K23Rik, 2310074I15Rik, D330041I19Rik, D830007G01Rik}, Mapk13 (mitogen-activated protein kinase 13) [NCBI Gene 26415] {aka SAPK4, Serk4}, Nppa (natriuretic peptide type A) [NCBI Gene 230899] {aka ANP, Anf, CDD, Pnd}, Mcam (melanoma cell adhesion molecule) [NCBI Gene 84004] {aka 1-gicerin, CD146, CD149, Muc18, s-endo, s-gicerin}, Itga7 (integrin alpha 7) [NCBI Gene 16404] {aka [a]7, alpha7}, Nucleolin (nucleolin multifunctional protein) [NCBI Gene 17975] {aka B530004O11Rik, C23, D0Nds28, D1Nds28, Ncl, Nucl}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Cox7c (cytochrome c oxidase subunit 7C) [NCBI Gene 12867] {aka COXVIIc, Cox7c1}, Obscn (obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF) [NCBI Gene 380698] {aka Gm878, UNC89}
- **Diseases:** diabetic cardiomyopathy (MESH:D058065), cardiomyocyte hypertrophy (MESH:D006984), TAC (MESH:D015877), cardiac muscle contraction (MESH:C536214), myocardial infarction (MESH:D009203), dislocation (MESH:D004204), death (MESH:D003643), heart failure (MESH:D006333), pressure overload (MESH:D019190), fibrosis (MESH:D005355), inflammation (MESH:D007249), pathological (MESH:D005598), aortic stenosis (MESH:D001024), analgesia (MESH:D000699), tumorigenesis (MESH:D063646), cardiac hypertrophy (MESH:D006332), cardiac contraction (MESH:D006331), hypertrophic (MESH:D002312), cardiomyopathies (MESH:D009202), arterial hypertension (MESH:D000081029), heart remodelling (MESH:D066253), cardiac remodelling (MESH:D020257)
- **Chemicals:** chloroform (MESH:D002725), sodium disulfite (MESH:C005200), formic acid (MESH:C030544), CaCl2 (MESH:D002122), 2-Chloroacetamide (MESH:C013874), lysine (MESH:D008239), buprenorphine (MESH:D002047), metamizole (MESH:D004177), dimethylamine (MESH:C034516), Atropine sulphate (MESH:D001285), Magnesium chloride (MESH:D015636), ethanol (MESH:D000431), glycerol (MESH:D005990), SDS (MESH:D012967), acid (MESH:D000143), DTT (MESH:D004229), Phosphopeptides (MESH:D010748), sodium deoxycholate (MESH:D003840), Urea (MESH:D014508), TFA (MESH:D014269), methionine (MESH:D008715), threonine (MESH:D013912), disulfide (MESH:D004220), isoflurane (MESH:D007530), Sodium orthovanadate (-), HCl (MESH:D006851), serine (MESH:D012694), Triton X-100 (MESH:D017830), PBS (MESH:D007854), calcium (MESH:D002118), nitrogen (MESH:D009584), Glucose (MESH:D005947), acetonitrile (MESH:C032159), methanol (MESH:D000432), EDTA (MESH:D004492), Fe-NTA (MESH:C020326), NaCl (MESH:D012965), Peptides (MESH:D010455), Rimadyl (MESH:C007005), Cysteine (MESH:D003545), DMSO (MESH:D004121), H2O (MESH:D014867), HEPES (MESH:D006531)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12317976/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12317976/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12317976/full.md

---
Source: https://tomesphere.com/paper/PMC12317976